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MEDICAL SCIENCES, BIOCHIMESTRY, ARDABIL, IRAN 6ARDABIL UNIVERSITY OF MEDICAL SCIENCES,
ARDABIL UNIVERSITY OF MEDICAL SCIENCES, ARDABIL, IRANPURPOSE: Natural antioxidants in foods may be used in prevention and treatment of oxidative stress and inﬂammation in
COPD. Therefore, this study aimed to evaluate the effect of conjugated linoleic acid (CLA) supplement as natural antioxidants on
oxidative stress levels, and MMP2 and MMP9 serum levels in COPD patients.
METHODS: This clinical trial study was conducted on 90 (supplement and control group) COPD patients. After obtaining
written consent, general information was collected from each patient using a validated and reliable questionnaire. Supplement
group received 3.2 g of CLA and those in the control group were given 3.2 g of placebo for 6 weeks on a daily basis.Fasting blood
samples were taken from all of the patients for testing of malondialdehyde, MMP2 and MMP9 levels at the beginning and end of
the study.
RESULTS: There were no signiﬁcant differences between the two groups with regard to mean age, smoking status, and serum
level of MDA at the beginning of the study. In the supplement group, the serum level of MDA decreased signiﬁcantly at the end of
the 6th week compared to that in the beginning of the study (p¼0.0004), while in the placebo group, the difference was found to
be insigniﬁcant. The serum level of MMP9 decreased signiﬁcantly in the supplement group, while in the placebo group its level
increased signiﬁcantly as compared to that at the beginning of the study (p,0.05)
CONCLUSIONS: that CLA supplementation may be helpful for COPD patients through inhibiting the production of oxidative
stress and controlling MMP9 serum levels
CLINICAL IMPLICATIONS: effective
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